Methemoglobinemia
Background
- Methemoglobin refers to ferric form of Hb (Fe3+) that is unable to bind O2
- Suspect in any patient with cyanosis not responsive to supplemental O2
- Caused by exposure to oxidizing agent
- Benzocaine
- Dapsone
- CN kit
- Antimalarials
Clinical Features
- Depends on level of metHb
- Pts with anemia or preexisting cardiopulmonary disease will show symptoms sooner
- <20%: asymptomatic, gray-blue cyanosis
- 20-30%: anxiety, HA, weakness, light-headedness, tachycardia
- 50-60%: myocardial ischemia, dysrhythmias, depressed mental status, seizure
- >70%: usually fatal
Differential Diagnosis
Diagnosis
- Co-oximetry
- Measures relative levels of oxyhemoglobin, carboxyhemoglobin, methemoglobin, reduced hemoglobin
- Usually performed on arterial blood sample, but fingertip CO-oximeter devices are available
- SpO2 will initially be falsely elevated
- Once MetHb >30% → SpO2 will fall to 80-85%
- "Chocolate brown" color of blood
Management
- Methylene Blue
- Treat if symptomatic OR asymptomatic w/ MetHb >25%
- 1-2mg/kg Methylene Blue IV over 5min; repeat dose if no effect
- Improvement seen within 20min
